ETO interacting proteins
- PMID: 15156183
- DOI: 10.1038/sj.onc.1207674
ETO interacting proteins
Abstract
The 8;21 translocation produces a fusion between the ETO gene and that encoding the myeloid transcription factor AML1. The AML1-ETO fusion substitutes the majority of the ETO protein for the coregulator recruitment domains of AML1. Biochemical analyses of ETO have led to the identification of numerous interacting proteins including many corepressors. Importantly, the proteins interacting with ETO are different from those of wild-type AML1, suggesting that altered coregulator recruitment underlies the oncogenic properties of AML1-ETO. The list of corepressors capable of binding ETO includes histone deacetylases (HDACs) and components of distinct HDAC core complexes. These investigations have provided mechanistic insight into corepressor recruitment by ETO and clues to the leukemogenic activity of AML1-ETO.
Similar articles
-
AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.Cancer Res. 2004 Jul 1;64(13):4547-54. doi: 10.1158/0008-5472.CAN-03-3689. Cancer Res. 2004. PMID: 15231665
-
Domains involved in ETO and human N-CoR interaction and ETO transcription repression.Leuk Res. 2004 Apr;28(4):409-14. doi: 10.1016/j.leukres.2003.08.016. Leuk Res. 2004. PMID: 15109542
-
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.Mol Cell Biol. 2001 Oct;21(19):6470-83. doi: 10.1128/MCB.21.19.6470-6483.2001. Mol Cell Biol. 2001. PMID: 11533236 Free PMC article.
-
Retinoid receptors in health and disease: co-regulators and the chromatin connection.Semin Cell Dev Biol. 1999 Apr;10(2):215-25. doi: 10.1006/scdb.1999.0303. Semin Cell Dev Biol. 1999. PMID: 10441075 Review.
-
Coactivator and corepressor complexes in nuclear receptor function.Curr Opin Genet Dev. 1999 Apr;9(2):140-7. doi: 10.1016/S0959-437X(99)80021-5. Curr Opin Genet Dev. 1999. PMID: 10322133 Review.
Cited by
-
HDACs and HDAC Inhibitors in Cancer Development and Therapy.Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):a026831. doi: 10.1101/cshperspect.a026831. Cold Spring Harb Perspect Med. 2016. PMID: 27599530 Free PMC article. Review.
-
Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity.Blood. 2009 Apr 9;113(15):3558-67. doi: 10.1182/blood-2008-06-161307. Epub 2009 Feb 9. Blood. 2009. PMID: 19204326 Free PMC article.
-
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia.Int J Mol Sci. 2019 Jan 16;20(2):350. doi: 10.3390/ijms20020350. Int J Mol Sci. 2019. PMID: 30654457 Free PMC article. Review.
-
Computational Modeling of Gene-Specific Transcriptional Repression, Activation and Chromatin Interactions in Leukemogenesis by LASSO-Regularized Logistic Regression.IEEE/ACM Trans Comput Biol Bioinform. 2021 Nov-Dec;18(6):2109-2122. doi: 10.1109/TCBB.2021.3078128. Epub 2021 Dec 8. IEEE/ACM Trans Comput Biol Bioinform. 2021. PMID: 33961561 Free PMC article.
-
A neurogenetic mechanism of experience-dependent suppression of aggression.Sci Adv. 2022 Sep 9;8(36):eabg3203. doi: 10.1126/sciadv.abg3203. Epub 2022 Sep 7. Sci Adv. 2022. PMID: 36070378 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials